Key result
The AT1R A1166C polymorphism was not significantly associated with the presence of acute coronary syndrome in the studied Iranian population (p=0.85).
Why the study?
Is the AT1R A1166C polymorphism associated with acute coronary syndrome in an Iranian population?
Cross-Sectional (n=263)
No
Is the AT1R A1166C polymorphism associated with acute coronary syndrome in an Iranian population?
p-value: p=0.85
The AT1R A1166C polymorphism does not appear to be associated with the presence of acute coronary syndrome in the Iranian population.
No association in this Iranian cohort does not support genotyping for ACS risk; leaves open ethnic-specific validation in larger studies.
BACKGROUND: There are very limited data for Iranian populations on the predisposing genetic factors for acute coronary syndrome (ACS). OBJECTIVES: The objective of the present study was to investigate the association of the angiotensin II type 1 receptor (AT1R) gene polymorphism and ACS in an Iranian population. PATIENTS AND METHODS: This cross-sectional study was conducted among 263 subjects (97 men and 166 women). Patients (n = 128) aged 30 - 80 years with chest pain were recruited from the emergency department of Ghaem Hospital (Mashhad, Iran). A 12-lead electrocardiograph plus creatine kinase MB (CK-MB) levels were used as the basis for the diagnosis of myocardial ischemia. The control group was selected from age-matched healthy subjects (n = 135). Non-enzymatic kits were used for extraction of DNA from blood samples. Polymerase chain reaction (PCR) was performed to amplify the DNA fragments. For restriction fragment length polymorphism (RFLP) determination, the DdeI enzyme was used to digest the amplified DNA fragments. Statistical analyses were performed using SPSS version 13.0. RESULTS: There was no statistical difference in the genotype frequency of patients and healthy subjects with regard to age and gender (P > 0.05). CONCLUSIONS: The AT1R A1166C polymorphism appeared not to be associated with the presence of ACS in the population studied.
No takes yet. Share an insight, caveat, or question.
Delshad et al. (2016) conducted a cross-sectional in Acute Coronary Syndrome (n=263). AT1R A1166C polymorphism vs. Healthy controls was evaluated on Difference in AT1R A1166C genotype frequencies (AA, AC, CC) between ACS patients and healthy controls (p=0.85). The AT1R A1166C polymorphism was not significantly associated with the presence of acute coronary syndrome in the studied Iranian population (p=0.85).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: